#psychedelic-medicine

#psychedelic-medicine

FDA's rejection of MDMA-assisted therapy signals a need for rigorous trial standards in psychedelic research, despite initial promising results. [ more ]

The FDA is nearing a decision on using MDMA for PTSD treatment, with lobbying for approval due to the potential positive impact on mental health, particularly for veterans. [ more ]

Psilocybin induces altered states of consciousness, enhancing sensitivity to the environment, visual disturbances, and mystical experiences in a span of 4-6 hours.

Research indicates psilocybin alters brain networks related to introspective thinking, shedding light on the neurobiological basis of psychedelic experiences.

The study of brain changes during psychedelic trances opens doors for therapeutic applications against psychiatric disorders like resistant depression and addictions. [ more ]

Researchers are investigating the therapeutic potential of 5-MeO-DMT from the Sonoran Desert toad for mental health disorders. [ more ]